No Data
Edan Instruments, Inc. (SZSE:300206) Goes Ex-Dividend Soon
Edan Instruments, Inc.: First Quarter Report 2026
Lipoint Instrument (300206.SZ) announced its Q1 financial results, with a net profit attributable to shareholders of RMB 105 million, representing a 61.39% increase.
Lifang Instruments (300206.SZ) released its first-quarter report for 2026. The company's operating revenue was RMB 516 million, representing a year-on-year increase of 22.82%. The net profit attributable to shareholders of the listed company was RMB 105 million, reflecting a year-on-year growth of 61.39%. The net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was RMB 100 million, increasing by 66.75% year-on-year. The basic earnings per share were RMB 0.1812.
Mindray Medical: 2025 Annual Report
Mindray Medical: Summary of the 2025 Annual Report
EDAN Launches EDAN Nano OB Assist, an AI-Enabled Handheld Ultrasound, to Expand Access to Prenatal Screening in Africa
Edan Instruments (SZSE:300206) Sheds CN¥516m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Three Years